Navigation Links
Freezor 5

ProductsFreezor 5
Company CryoCath Technologies, Inc.
Item Freezor 5
Features 
  • 7 French diameter
  • uni-directional catheter
  • 110cm working length
  • 4mm ablation electrode
  • 3 reaches (short, medium, long)
  • 4 mapping electrodes with 2-5-2 spacing
  • Description CryoCath has developed a minimally invasive cryocatheter to treat atrioventricular nodal reentrant tachycardia. It delivers a very high level of safety through accurate site confirmation, pinpoint site precision, minimal tissue disruption, and minimal risk of thrombus and stenosis.
    Freezor is a flexible, single-use, minimally invasive CryoAblation catheter designed to create focal lesions to treat AVNRT, an arrhythmia where procedural precision is of critical importance. Freezor can create temperatures at its tip as low as -75C inside a beating heart. Freezor offers a site-testing capability - which involves a technique called CryoMapping - which may aid for physicians to avoid unwanted electrophysiological effects on AV node conduction.
    Info CryoCath Technologies, Inc.
    Customer Service: (877) 464-2796
    Web site: http://www.cryocath.com

    Related medicine products :

    1. Freezor 3
    2. Freezor 1
    3. Freezor Xtra
    4. Freezor MAX
    TAG: Freezor
    ... advance of digital imaging technology, pathology ...formats, allowing for easier manipulation, analysi...in digital pathology imaging is analogous to the c...tinuing to occur in hospital imaging departments a...
    The CellTracks® Analyzer II is a semi-automated fluorescence microscope used to enumerate fluorescently labeled cells that are immunomagnetically selected and aligned. The product consists of the
    These Iron Control Slides make an excellent addition to your laboratory. Packed ten (10) control slides per box. Use SDL's Snap n' Stain for Iron Staining Kit alongside to save time an money mixing r
    PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques.
    Medicine Products:
    (Date:7/9/2008)...day OnBase deployment critical in electronic healt...atients, CLEVELAND, July 9 /PRNewswire/ -- Hyland...ocument management software suite, announced that ...since the deployment of,OnBase in March. Based in ...states, SSM is a forward-thinking health care prov...
    (Date:7/9/2008)... March 8 - 11, 2009, CLEVELAND, Jul...e,innovative ideas and experiences, the Managed Ca...nnual forum for CIOs and senior health-plan leader...oming MCEG forum, which has earned a reputation fo...nities, will be at the Sheraton Wild,Horse Pass Re...
    (Date:7/9/2008)... This first-of-its-kind Diamond Elite ...ot to graze, chip or develop cracks. , ... After two years in development, The Kitchen Bath ...eased the newest design in walk-in tubs: Diamond ... low 1-inch-high entry and is 3-times thicker and ...
    (Date:7/9/2008)... The Detail Bag II is an integrated sal...s and other sales professionals who carry samples.... than the first Detail Bag (DB-XL). This thin, l...pired by direct customer feedback. The DB2 is con...ith a steel frame for durability and functionality...
    Breaking Medicine News(10 mins):Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:Affordability Crisis in Managed Care Explored at Conference of Health Plan Executives 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 2Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 3
    ...s one of the most devastating diseases to hit olde...searchers from the Rush Institute //on Healthy Agi...of Alzheimer’s for the use of public health planni... of study and the source. This study used the Unit...
    ... transplants have become an increasingly common pr...restore the immune system. But it can take months ...lls, and during that time the patient is at risk f...ave taken cell transplants one step further with i...
    ...alcohol can initially help someone fall asleep, it...night, reports the journal Alcoholism: Clinical & ...l cause the average person to fall asleep sooner t...ie of the University of Calgary. "However, falling...
    ...dy finds angioplasty should be the treatment of ch...al they initially //go to doesn't offer angioplast...her facility for treatment. Research has shown hea... are treated with angioplasty to open up the clogg...
    Other Medicine News:
    (Date:7/9/2008)...-- Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) to...ending,dose Phase 1b clinical trial of APD791 to e...d pharmacodynamics. APD791 is Arena,s internally,d...atment of arterial,thrombosis and other related co...ouble-blind, placebo-controlled,multiple-ascendin...
    (Date:7/8/2008)...wswire/ -- A great deal of,scientific evidence sho...statins can help prevent coronary artery disease. ...well documented, as many as 40 percent of,patients...rug for less than,one year. Doctors believe that s... poor understanding of statin benefits and patient...
    (Date:7/8/2008)...dpoints in ENGAGE Trial, KENILWORTH, N.J., July 8...(NYSE: SGP ) announced today that corifollitropin...ant (SFS) met its primary endpoints,in the Phase I...g a,Schering-Plough-sponsored symposium at the 24t...Reproduction and Embryology (ESHRE) in Barcelona,...
    (Date:7/7/2008)...ANA598 and ANA773 Acting via Independent ... Conference Call Today at 2:00 PM PDT, SAN...armaceuticals,Inc. (Nasdaq: ANDS ) announced tod...he Toll-Like Receptor-7 (TLR7) mechanism for the,t...cal pharmacology testing,and the results of comple...
    Breaking Medicine Technology:Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol 2Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol 3Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Mergers and New Facilities Abound in Washington D C Suburbs 12857 1Mergers and New Facilities Abound in Washington D C Suburbs 12857 2American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 12855 1American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 12855 2Abbott Genentech and WEHI Collaborate to Research and Develop New Anti Cancer Drugs 12853 1Abbott Genentech and WEHI Collaborate to Research and Develop New Anti Cancer Drugs 12853 2A Once Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD Related Inflammation Could Achieve Blockbuster Status 12851 1A Once Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD Related Inflammation Could Achieve Blockbuster Status 12851 2